Clinical Trials in Nashville

Showing 1041-1060 of 20,298 trials

A Study of HLD-0117 in Patients With Metastatic Breast Cancer

NCT07524855

Assessment of the safety and efficacy of HLD-0117 as monotherapy in patients with estrogen receptor positive (ER+) metastatic breast cancer (MBC) or locally advanced breast cancer that have progressed on prior systemic therapies.

Metastatic Breast Cancer

Halda Therapeutics OpCo, Inc.33 participantsStarted Mar 2026

Sarasota, Florida, United States • Nashville, Tennessee, United States • Fairfax, Virginia, United States

AVAILABLE< 1 mile

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

NCT05795361

As the HGT-HIT-046 (NCT01506141) and SHP609-302 (NCT02412787) studies are completed and closed, this post-trial access (PTA) program provides TAK-609 to participants in these studies for whom the benefit:risk ratio of continued treatment with idursulfase-IT remains positive.

Hunter Syndrome

Takeda

Phoenix, Arizona, United States • Oakland, California, United States • Wilmington, Delaware, United States +19 more locations

A Study of HLD-0117 in Patients With Metastatic Breast Cancer

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

Find Trials by Condition in Nashville

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Rapid HCV Treatment Access for Persons Who Use Drugs

A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

Comparing Two Different Emotion Therapies for Autistic Youth and Young Adults

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

Pharmacogenomic Informed Statin Prescribing

Obeticholic Acid for Prevention in Barrett's Esophagus

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Micro-UltraSound In Cancer - Active Surveillance